Related references
Note: Only part of the references are listed.Complement-mediated inflammation and injury in brain dead organ donors
Felix Poppelaars et al.
MOLECULAR IMMUNOLOGY (2017)
Role of the lectin complement pathway in kidney transplantation
Conrad A. Farrar et al.
IMMUNOBIOLOGY (2016)
Structural basis for therapeutic inhibition of complement C5
Matthijs M. Jore et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Complement-here, there and everywhere, but what about the transplanted organ?
R. M. Montero et al.
SEMINARS IN IMMUNOLOGY (2016)
Structural basis for therapeutic inhibition of complement C5
Matthijs M. Jore et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD
Erin K. Wagner et al.
SCIENTIFIC REPORTS (2016)
Eculizumab for Treatment of Rapidly Progressive C3 Glomerulopathy
Moglie Le Quintrec et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
C3 Glomerulopathy: Clinicopathologic Features and Predictors of Outcome
Nicholas R. Medjeral-Thomas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Clinical Findings, Pathology, and Outcomes of C3GN after Kidney Transplantation
Ladan Zand et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Eculizumab in dense-deposit disease after renal transplantation
Ana Sanchez-Moreno et al.
PEDIATRIC NEPHROLOGY (2014)
Atypical Hemolytic Uremic Syndrome Recurrence After Kidney Transplantation
Dany Matar et al.
TRANSPLANTATION (2014)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Eculizumab and recurrent C3 glomerulonephritis
Sevgi Gurkan et al.
PEDIATRIC NEPHROLOGY (2013)
Acute But Transient Release of Terminal Complement Complex After Reperfusion in Clinical Kidney Transplantation
Dorottya K. de Vries et al.
TRANSPLANTATION (2013)
Recurrent Dense Deposit Disease After Renal Transplantation: An Emerging Role for Complementary Therapies
J. A. McCaughan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
Andrew S. Bomback et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Pathology after Eculizumab in Dense Deposit Disease and C3 GN
Leal C. Herlitz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL (2012)
Genetics of HUS:: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
Jessica Caprioli et al.
BLOOD (2006)
Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience
MC Braun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Share Paper
